Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.

about

Zebrafish as a Model Organism for the Development of Drugs for Skin Cancer.Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.

P2860

Q38656012-B31656FC-860D-459C-A79C-67F5007E386A Q54117733-365BABE3-0AD2-4AA6-A350-4740AF323491

P2860

Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.

Item

http://www.wikidata.org/entity/Q38756969

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.

@en

type

Item

label

Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.

@en

prefLabel

Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.

@en

P1476

Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.

@en

P2093

Andreas Schröck

http://www.w3.org/2001/XMLSchema#string

Angela Queisser

http://www.w3.org/2001/XMLSchema#string

Anne von Mässenhausen

http://www.w3.org/2001/XMLSchema#string

Christine Sanders

http://www.w3.org/2001/XMLSchema#string

Friedrich Bootz

http://www.w3.org/2001/XMLSchema#string

Glen Kristiansen

http://www.w3.org/2001/XMLSchema#string

Johannes Brägelmann

http://www.w3.org/2001/XMLSchema#string

Jutta Kirfel

http://www.w3.org/2001/XMLSchema#string

Peter Brossart

http://www.w3.org/2001/XMLSchema#string

Stefan Duensing

http://www.w3.org/2001/XMLSchema#string

P2860

Discoidin domain receptors promote α1β1- and α2β1-integrin mediated cell adhesion to collagen by enhancing integrin activation

The discoidin domain receptor tyrosine kinases are activated by collagen

Sensing extracellular matrix: an update on discoidin domain receptor function

Cell signaling by receptor tyrosine kinases

Nonparametric Estimation from Incomplete Observations

Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers

Cancer statistics, 2010

Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen

P304

2359-2369

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.30279

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Claudia Lengerke

Martina Konantz

P577

2016-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27434411

http://www.w3.org/2001/XMLSchema#string

Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.

about

P2860

P2860

Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698